MX2010004469A - Compuestos de fenilpirrolidina. - Google Patents
Compuestos de fenilpirrolidina.Info
- Publication number
- MX2010004469A MX2010004469A MX2010004469A MX2010004469A MX2010004469A MX 2010004469 A MX2010004469 A MX 2010004469A MX 2010004469 A MX2010004469 A MX 2010004469A MX 2010004469 A MX2010004469 A MX 2010004469A MX 2010004469 A MX2010004469 A MX 2010004469A
- Authority
- MX
- Mexico
- Prior art keywords
- phenylpyrrolidine
- compounds
- phenylpyrrolidine compounds
- prevention
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La invención proporciona nuevos compuestos de fenilpirrolidina de la fórmula general (I), su uso para el tratamiento o prevención de desórdenes melatoninérgicos y sus composiciones.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200702800A ES2331276B1 (es) | 2007-10-25 | 2007-10-25 | Compuestos de fenilpirrolidina. |
PCT/EP2008/064390 WO2009053441A1 (en) | 2007-10-25 | 2008-10-23 | Phenylpyrrolidine compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010004469A true MX2010004469A (es) | 2010-07-06 |
Family
ID=40291255
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010004469A MX2010004469A (es) | 2007-10-25 | 2008-10-23 | Compuestos de fenilpirrolidina. |
Country Status (21)
Country | Link |
---|---|
US (1) | US20120184594A1 (es) |
EP (1) | EP2203422B1 (es) |
JP (1) | JP2011500764A (es) |
KR (1) | KR20100072287A (es) |
CN (1) | CN101878198A (es) |
AR (1) | AR069002A1 (es) |
AT (1) | ATE513809T1 (es) |
AU (1) | AU2008316473A1 (es) |
BR (1) | BRPI0817660A2 (es) |
CA (1) | CA2703458A1 (es) |
CL (1) | CL2008003141A1 (es) |
DK (1) | DK2203422T3 (es) |
ES (2) | ES2331276B1 (es) |
MX (1) | MX2010004469A (es) |
PL (1) | PL2203422T3 (es) |
PT (1) | PT2203422E (es) |
RU (1) | RU2010120845A (es) |
SI (1) | SI2203422T1 (es) |
TW (1) | TW200920353A (es) |
UY (1) | UY31425A1 (es) |
WO (1) | WO2009053441A1 (es) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5753709A (en) * | 1995-06-07 | 1998-05-19 | Bristol-Myers Squibb Company | N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics |
WO2001002392A1 (en) * | 1999-06-30 | 2001-01-11 | Bristol-Myers Squibb Company | Heterocyclic aminopyrrolidine derivatives as melatonergic agents |
-
2007
- 2007-10-25 ES ES200702800A patent/ES2331276B1/es not_active Withdrawn - After Issue
-
2008
- 2008-10-23 DK DK08842890.9T patent/DK2203422T3/da active
- 2008-10-23 AT AT08842890T patent/ATE513809T1/de active
- 2008-10-23 KR KR1020107008900A patent/KR20100072287A/ko not_active Application Discontinuation
- 2008-10-23 ES ES08842890T patent/ES2368697T3/es active Active
- 2008-10-23 CN CN2008801131031A patent/CN101878198A/zh active Pending
- 2008-10-23 SI SI200830368T patent/SI2203422T1/sl unknown
- 2008-10-23 PL PL08842890T patent/PL2203422T3/pl unknown
- 2008-10-23 US US12/739,708 patent/US20120184594A1/en not_active Abandoned
- 2008-10-23 WO PCT/EP2008/064390 patent/WO2009053441A1/en active Application Filing
- 2008-10-23 AR ARP080104616A patent/AR069002A1/es not_active Application Discontinuation
- 2008-10-23 CA CA2703458A patent/CA2703458A1/en not_active Abandoned
- 2008-10-23 PT PT08842890T patent/PT2203422E/pt unknown
- 2008-10-23 MX MX2010004469A patent/MX2010004469A/es active IP Right Grant
- 2008-10-23 JP JP2010530463A patent/JP2011500764A/ja not_active Abandoned
- 2008-10-23 BR BRPI0817660A patent/BRPI0817660A2/pt not_active IP Right Cessation
- 2008-10-23 RU RU2010120845/04A patent/RU2010120845A/ru not_active Application Discontinuation
- 2008-10-23 EP EP08842890A patent/EP2203422B1/en not_active Not-in-force
- 2008-10-23 AU AU2008316473A patent/AU2008316473A1/en not_active Abandoned
- 2008-10-24 UY UY31425A patent/UY31425A1/es unknown
- 2008-10-24 TW TW097140810A patent/TW200920353A/zh unknown
- 2008-10-24 CL CL2008003141A patent/CL2008003141A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP2203422B1 (en) | 2011-06-22 |
WO2009053441A1 (en) | 2009-04-30 |
ES2368697T3 (es) | 2011-11-21 |
KR20100072287A (ko) | 2010-06-30 |
ES2331276B1 (es) | 2010-10-21 |
BRPI0817660A2 (pt) | 2015-09-29 |
US20120184594A1 (en) | 2012-07-19 |
AR069002A1 (es) | 2009-12-23 |
PT2203422E (pt) | 2011-09-26 |
CN101878198A (zh) | 2010-11-03 |
DK2203422T3 (da) | 2011-10-10 |
ATE513809T1 (de) | 2011-07-15 |
CL2008003141A1 (es) | 2009-03-06 |
RU2010120845A (ru) | 2011-11-27 |
EP2203422A1 (en) | 2010-07-07 |
TW200920353A (en) | 2009-05-16 |
UY31425A1 (es) | 2009-04-30 |
AU2008316473A1 (en) | 2009-04-30 |
ES2331276A1 (es) | 2009-12-28 |
JP2011500764A (ja) | 2011-01-06 |
SI2203422T1 (sl) | 2011-10-28 |
CA2703458A1 (en) | 2009-04-30 |
PL2203422T3 (pl) | 2011-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009008347A (es) | Oxabicicloheptanos y oxabicicloheptenos, su preparacion y uso. | |
MY153915A (en) | Organic compounds | |
MY162157A (en) | Substituted indole mcl-1 inhibitors | |
PH12015500550A1 (en) | Anti-notch1 nrr antibodies and methods using same | |
TW200738724A (en) | Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
MX2020012825A (es) | Compuestos multiciclicos y metodos de uso de los mismos. | |
MX2011007750A (es) | Composiciones y metodos para inhibicion de la ruta jak. | |
PT1984357E (pt) | Compostos de 2,4-pirimidinadiamina para tratamento ou prevenção de doenças autoimunes | |
TW201713640A (en) | Bruton's tyrosine kinase inhibitors | |
IN2012DN00869A (es) | ||
UA97502C2 (ru) | Кристаллическая твердая основа разагилина | |
MX2012002366A (es) | Agonistas novedosos de receptores beta 3 andrenergicos derivados de pirrolidina. | |
MX2009000657A (es) | Composiciones y metodos para el tratamiento de mucositis. | |
MX2009010960A (es) | Compuestos heterociclicos y sus metodos de uso. | |
UA99936C2 (en) | Biaryl substituted azabicyclic alkane derivatives | |
TW200724140A (en) | Hydantoin compounds | |
GB2466912A (en) | Compositions and methods for treating lysosomal disorders | |
MX2009013353A (es) | Compuestos activadores de telomerasa y metodos para su uso. | |
WO2009009417A3 (en) | Pharmaceutical compositions and methods of preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion | |
GEP20135959B (en) | Aryl piperazine and their usage as alpha2c antagonists | |
MX2010007543A (es) | Inhibidores de iap. | |
WO2007112121A3 (en) | Tetracycline compounds and methods of treatment | |
MX2009009490A (es) | Profarmacos novedosos. | |
MX2010000956A (es) | Derivados de isoftalamida que inhiben actividad de beta-secretasa. | |
MX2010001303A (es) | Compuestos terapeuticos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |